David Ledbetter is chief clinical officer of Dascena, a personalized medicine company.
David Ledbetter
Chief clinical officer
Dascena
From this contributor
There are no autism-specific genes, just brain genes
There is not yet a single example of a gene that, when mutated, increases the likelihood of autism but not of other neurodevelopmental conditions, including intellectual disability.
There are no autism-specific genes, just brain genes
By
David Ledbetter, Scott Myers
23 March 2021 | 5 min read
Developmental disorders should be viewed as continuum
Intellectual disability, autism, epilepsy and schizophrenia should be considered part of a spectrum of developmental brain dysfunction, says David Ledbetter.
Developmental disorders should be viewed as continuum
By
David Ledbetter
6 May 2013 | 3 min read
Explore more from The Transmitter
The silent majority: How astrocytes shape the brain across scales
Melissa Cooper talks to Mac Shine about her new work that reveals how these glial cells—long dismissed as the brain’s housekeepers—wire together in precise, long-range networks that remodel in response to experience.
The silent majority: How astrocytes shape the brain across scales
Melissa Cooper talks to Mac Shine about her new work that reveals how these glial cells—long dismissed as the brain’s housekeepers—wire together in precise, long-range networks that remodel in response to experience.
By
Mac Shine
12 May 2026 | 29 min watch
Untangling genetic effects, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 11 May.
Untangling genetic effects, and more
Here is a roundup of autism-related news and research spotted around the web for the week of 11 May.
By
Jill Adams
12 May 2026 | 2 min read
The next unit of science: Is the scientific paper due to be replaced?
Artificial intelligence is pushing scientific publishing to the brink. For a field as sprawling as neuroscience, the crisis may also be an opportunity to finally connect findings across subfields.
The next unit of science: Is the scientific paper due to be replaced?
Artificial intelligence is pushing scientific publishing to the brink. For a field as sprawling as neuroscience, the crisis may also be an opportunity to finally connect findings across subfields.
By
Tim Requarth
11 May 2026 | 11 min read